Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FX3LU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $150,437
Award facts
- Contract value 100% obligated
- $150,436.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $150,436.99 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen auto-injectors. The non-competitive delivery order, issued on October 17, 2025, with a completion date of October 20, 2025, was placed under a firm fixed-price arrangement and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supplies pharmaceuticals and medical commodities globally to support military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the DLA and other defense agencies. The company's federal contracting history demonstrates its capability to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains, from brand-name medications to generic drugs and medical devices, consistently securing competitively awarded contracts through open procurement processes. The Dupixent delivery represents one of numerous pharmaceutical product deliveries the company manages for military and veteran healthcare systems under its primary vendor relationships with federal medical supply chains.
Quick answers
Who was awarded contract SPE2DB26FX3LU?
SPE2DB26FX3LU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FX3LU worth?
The government has obligated $150,437 on SPE2DB26FX3LU.
Is contract SPE2DB26FX3LU an order under another contract?
Yes. SPE2DB26FX3LU is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3LU competed?
The extent of competition for SPE2DB26FX3LU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award